-

Feinstein Institutes CEO to Present Elsberg Lecture About Bioelectronic Medicine

Kevin J. Tracey, MD, selected to present prestigious neurosurgery lecture

original Feinstein Institutes CEO to give Elsberg Lecture (Photo: Business Wire)

Feinstein Institutes CEO to give Elsberg Lecture (Photo: Business Wire)

MANHASSET, N.Y.--(BUSINESS WIRE)--The Feinstein Institutes for Medical Research President and CEO Kevin J. Tracey, MD, will present the New York Society for Neurosurgery (NYSN) 2020 Elsberg Lecture about the emerging field of bioelectronic medicine. Dr. Tracey’s lecture will be delivered January 29 at 6:30 pm at The University Club of New York.

To register for the event, click here.

The Elsberg Lecture is named for Charles. A. Elsberg, one of the founding fathers of modern neurosurgery. Dr. Tracey’s lecture titled, “Bioelectronic Medicine – The New Frontier in Neurosurgery,” will expand the medical and scientific community’s knowledge of bioelectronic medicine. Dr. Tracey’s will outline his discovery of the inflammatory reflex, which has contributed greatly to the emerging field of bioelectronic medicine. His research found that the vagus nerve, a nerve located in the neck, is involved in controlling inflammation. Bioelectronic medicine builds on this discovery and looks to use technology to tap into the nervous system to help the body treat disease and injury without the use of pharmaceuticals or experiencing significant side effects.

“The mission of the New York Society for Neurosurgery to cultivate life-long learning and support excellence in research synchronizes with my mission and the mission of the Feinstein Institutes: to produce knowledge to cure disease,” said Dr. Tracey. “I am honored and humbled to join those who delivered Elsberg Lectures, and I hope that sharing my life’s work to the audience will get us closer to finding solutions to cure disease.”

Current president of NYSN, Raj K. Narayan, MD, will introduce Dr. Tracey at the event. Dr. Narayan is a Feinstein Institutes professor in the Institute of Bioelectronic Medicine and Northwell Health’s senior vice president and executive director of neurosurgery services.

About the Feinstein Institutes

The Feinstein Institutes for Medical Research is the research arm of Northwell Health, the largest health care provider and private employer in New York State. Home to 50 research labs, 2,500 clinical research studies and 5,000 researchers and staff, the Feinstein Institutes raises the standard of medical innovation through its five institutes of behavioral science, bioelectronic medicine, cancer, health innovations and outcomes, and molecular medicine. We make breakthroughs in genetics, oncology, brain research, mental health, autoimmunity, and are the global scientific leader in bioelectronic medicine – a new field of science that has the potential to revolutionize medicine. For more information about how we produce knowledge to cure disease, visit feinstein.northwell.edu.

Contacts

Matthew Libassi
516-465-8325
mlibassi@northwell.edu

Industry:

Feinstein Institutes for Medical Research

Release Summary
Kevin J. Tracey, MD, selected to present prestigious neurosurgery lecture
Release Versions
English

Contacts

Matthew Libassi
516-465-8325
mlibassi@northwell.edu

More News From Feinstein Institutes for Medical Research

Northwell to Launch Long Island’s First Pancreas Transplant Program

MANHASSET, N.Y.--(BUSINESS WIRE)--Northwell Health has received approval to launch Long Island’s first adult pancreas transplant program, according to a letter from the New York State Department of Health (DOH). The Northwell Transplant Institute at North Shore University Hospital (NSUH) recently hosted a site visit with DOH officials, the final hurdle before opening the program to new patients. Northwell’s pancreas program will open access to patients across the greater New York and southern C...

32BJ Health Fund and Northwell Direct Announce Largest Direct Healthcare Contract of its Kind in the Country, Delivering Major Savings and Expanding Access to Care

NEW YORK--(BUSINESS WIRE)--32BJ Health Fund, the union health fund representing 100,000 building service workers in the New York metro area, and Northwell Direct, a direct-to-employer health care network that partners directly with employers and labor unions to provide health benefits solutions to their employees, today announced a historic deal that will significantly expand access to high-quality care for 32BJ members and their families while delivering dramatic savings to patients, unions an...

Feinstein Institutes’ Researchers Develop Promising Therapeutic for Sepsis-Induced Acute Lung Injury

MANHASSET, N.Y.--(BUSINESS WIRE)--Scientists at Northwell Health’s Feinstein Institutes for Medical Research are making strides in controlling the severe inflammation that is the hallmark of sepsis. This severe condition occurs when the body’s immune system reaction to infection causes it to attack its own tissues and organs, often resulting in organ failure or death. Researchers have uncovered a critical mechanism driving acute lung injury (ALI) in sepsis, identifying a novel subset of neutrop...
Back to Newsroom